an independent news feed from Current Medicine Group™
- Latest oncology research
- Clinical trials
- Healthcare initiatives
- Practice guidelines
-
- Sep 1, 2010
- Physicians not confident in knowledge about prostate cancer screening US primary care physicians are able to correctly identify prostate cancer risk factors but are not confident in their knowledge about prostate cancer screening and overall prostate cancer risk, show study results.
-
- Aug 31, 2010
- Computer-based decisional aid improves men’s prostate cancer screening knowledge A computer-based decision aid offered at the workplace can significantly improve men’s knowledge and decision-making ability regarding prostate cancer screening, show US study results.
-
- Aug 31, 2010
- FASN inhibition could reduce prostate cancer mortality in overweight men US research results suggest that overexpression of fatty acid synthase in tumors could increase prostate cancer-specific mortality, particularly in overweight and obese men.
-
- Aug 27, 2010
- Obese men should have prostate cancer screen adjusted for BMI Overweight and obese men may have diminished prostate cancer detection owing to low prostate-specific antigen levels, report US researchers who recommend adjusting prostate cancer screening to allow for the impact of body mass index.
-
- Aug 26, 2010
- Urine protein test represents novel biomarker for prostate cancer UK researchers have identified a novel urinary biomarker for the detection of prostate cancer.
-
- Aug 26, 2010
- Careful patient selection for active surveillance reduces treatment need Prostate cancer patients are unlikely to require definitive treatment after undergoing active surveillance if they are selected on the basis of strict low-risk criteria, suggest US researchers.
-
- Aug 25, 2010
- Initial treatment choice influences overall cost of prostate cancer The financial costs of treatment for prostate cancer vary according to the initial treatment that patients receive, report researchers, who add that the impact lasts beyond the short-term costs.
-
- Aug 24, 2010
- Bcl-2 protein expression could indicate prostate resistance to radiotherapy Patients with prostate tumors that express the anti-apoptotic protein B-cell lymphoma 2 experience a shorter time to biochemical failure after radiotherapy compared with men whose tumors do not express the protein, study results show.
-
- Aug 24, 2010
- Prostate length predicts urinary problems after brachytherapy The length of a man’s prostate could help predict the likelihood of him experiencing urinary problems after receiving brachytherapy for prostate cancer, report researchers.
-
- Aug 23, 2010
- Familial prostate cancer risk influenced by screening awareness Men with first-degree relatives who have prostate cancer are more likely to undergo prostate-specific antigen screening than those with no family history, report researchers who believe that the finding may bias the results of genetic studies investigating familial prostate cancer risk.
Not signed in
Information
This is an AstraZeneca International website for healthcare professionals and is not intended for the following audiences who should use the links below.
Subscribe to RSS News Feed